Intravenous vaccine shows promise against malaria.
Ingrid
I
Torjesen
D061605:Administration, Intravenous; D017321:Clinical Trials, Phase I as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods / Q000639:trends; D017780:Malaria Vaccines / Q000008:administration & dosage*; D016778:Malaria, Falciparum / Q000628:therapy*; D009316:National Institutes of Health (U.S.); D010963:Plasmodium falciparum / Q000276:immunology*; D014481:United States; D014613:Vaccines, Attenuated / Q000008:administration & dosage
D017780:Malaria Vaccines; D014613:Vaccines, Attenuated